| Patents for C07C 215 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton (11,541) |
|---|
| 01/24/2007 | EP1745007A2 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents |
| 01/23/2007 | US7166748 Durable coating compositions containing novel aspartic amine compounds |
| 01/23/2007 | US7166746 Fungicides for controlling and preventing an infestation of crop plants by phytopathogenic microorganisms; 2-hydroxy-N-[trans-2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-cyclohexyl]-2-phenyl-acetamide |
| 01/23/2007 | US7166745 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 01/23/2007 | US7166593 Glucocorticoid receptor modulators |
| 01/18/2007 | WO2007007828A1 Ethylenediamine derivative and method for producing same |
| 01/18/2007 | WO2007007628A1 Choline salt crystal of azulene compound |
| 01/18/2007 | US20070015818 Cyclic sulfone containing retroviral protease inhibitors |
| 01/18/2007 | CA2614545A1 Choline salt crystal of azulene compound |
| 01/17/2007 | EP1401575B1 Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 01/17/2007 | CN1898193A Method for producing optically active bisamidealcohol compound |
| 01/17/2007 | CN1898192A Metal compound, material for forming thin film and method for preparing thin film |
| 01/17/2007 | CN1295221C Substituted heterocyclic compounds |
| 01/17/2007 | CN1295144C Stabilized hydroxylamine solutions |
| 01/16/2007 | CA2257234C Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 01/11/2007 | WO2007003896A1 The treatment of inflammatory disorders and pain |
| 01/11/2007 | US20070010691 Enantioselective synthesis of enantiomerically enriched compounds |
| 01/11/2007 | US20070010585 Compounds having strong beta -galactosidase inhibitory activity or beta -glucosidase inhibitory activity; excellent solubility; pseudo-sugar; excellent treatment or prevention of glycolipid metabolic disorders |
| 01/11/2007 | CA2613905A1 The treatment of inflammatory disorders and pain |
| 01/10/2007 | CN1891683A Process for the preparation of n-monosubstituted beta-amino alcohols |
| 01/10/2007 | CN1294121C Substituted anilide derivatives, intermediates thereof, agricultural and horticultural chemicals and their usage |
| 01/04/2007 | WO2007000945A1 Molded catalyst for continuous production of mono(lower alkyl)monoalkanolamine and production method thereof |
| 01/04/2007 | WO2007000918A1 Benzylamine derivatives, method for optical resolution of benzylamine derivatives, process for production of benzylamine derivatives, process for production of optically active benzylamine derivatives, and process for production of (1r, 2s)-2-amino-1-(4-hydroxyphenyl)propan-1-ol |
| 01/04/2007 | WO2007000334A1 Phenyl-pyrazole derivatives as non-steroidal glucocorticoid receptor ligands |
| 01/03/2007 | EP1739075A1 Novel double para-phenylenediamines joined by a linker arm substituted with one or more hydroxyl, alkoxy and/or amino groups and use in dyeing |
| 01/03/2007 | EP1739073A1 New primary 2,3-disubstituted para-phenylendiamins and their use as oxidative colouring of keratinic fibers |
| 01/03/2007 | EP1737868A1 Stereoselective method for the production of clopidogrel |
| 01/03/2007 | CN1890244A Process for preparation of substituted amino alcohols |
| 01/03/2007 | CN1887855A Prepn of (S)-(+)-2-amino propanol |
| 01/03/2007 | CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/03/2007 | CN1293038C Prepn process of (1R, 2S)-(-)-ephedrine or its hydrochloride |
| 01/03/2007 | CN1292828C Apparatus for preparing C-11 choline and C-11 methionine |
| 01/02/2007 | US7157488 N-(2-(6-Fluoro-1H-indol-3-yl)ethyl)-3-(2,2,3,3-tetrafluoropropoxy)benzylamine; treating schizophrenia, anxiety, Alzheimer's disease, and cognitive disorders |
| 01/02/2007 | US7157477 Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis |
| 12/28/2006 | WO2005087752A8 Substituted hydroxyethylamine aspartyl protease inhibitors |
| 12/28/2006 | US20060293541 Continuous distillation in two stages, the low-boiling and the high-boiling fractions are taken off and discharged in the first stage, the intermediate-boiling fraction of triethanolamine and diethanolamine are distilled in the second stage |
| 12/28/2006 | US20060293530 Process for the manufacture of citalopram hydrobromide |
| 12/27/2006 | EP1735293A2 Substituted hydroxyethylamine aspartyl protease inhibitors |
| 12/27/2006 | EP1735266A1 Process for preparation of optically active 1-erythro-2-amino-1-phenyl-1-propanol |
| 12/27/2006 | EP1734942A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
| 12/27/2006 | EP1542942B1 Compositions containing ionic liquids and uses thereof, especially in organic synthesis |
| 12/27/2006 | CN1886362A Preparation and use of alkylating agents |
| 12/27/2006 | CN1884463A Cleaning agent for monoethanolamine regenerating device and its usage method |
| 12/26/2006 | US7154001 Formate salt of O-desmethyl-venlafaxine |
| 12/21/2006 | WO2006133652A1 Compounds, preparation process, and uses thereof used for interrupting reuptake of 5-hydroxytryptamine and norepinephrine or treating diseases such as depression et al. |
| 12/21/2006 | US20060286472 Photoconductive member |
| 12/21/2006 | CA2612413A1 Compounds for inhibition of 5-hydroxytryptamine and norepinephrine reuptake or for treatment of depression disorders, their preparation processes and uses thereof |
| 12/20/2006 | EP1359889B1 Primary intermediate for oxidative coloration of hair |
| 12/20/2006 | CN1882526A Process for the preparation of voglibose |
| 12/20/2006 | CN1880294A Polymorphic forms of dexketoprofen trometamol, preparation and pharmaceutical compositions thereof |
| 12/20/2006 | CN1290819C 2-aminopropane-1,3-glycol compound, its use as medicine and its synthetic intermediate |
| 12/20/2006 | CN1290818C Method for asymmetrical hydrogen transfer of alpha-imino keton for synthesizing chiral salbutamol |
| 12/19/2006 | CA2239805C Stabilized hydroxylamine solutions |
| 12/14/2006 | US20060281812 For urogenital disorders; improved side effect reduction, bioavailability, pharmacokinetics and half-life; N,N-diisopropyl-3-(2-methoxy-5-trifluoromethylphenyl)-3-phenylpropanamine tartrate |
| 12/13/2006 | EP1730099A2 Mitotic kinesin inhibitors |
| 12/13/2006 | CN1289465C Process for preparing levo- salbutamol or (R) salbutamol |
| 12/12/2006 | US7148239 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof |
| 12/12/2006 | CA2208439C Method for producing aminoethylethanolamine and/or hydroxyethyl piperazine |
| 12/07/2006 | WO2006129688A1 2-aminobutanol compound and pharmaceutical use thereof |
| 12/07/2006 | US20060275873 Autoinducer compound to improve the productivity of natamycin streptomyces strains |
| 12/06/2006 | EP1727783A1 Chiral tertiary aminoalkylnaphthols |
| 12/06/2006 | EP1727782A1 Method of producing aminophenol compounds |
| 12/05/2006 | US7145039 Transfection reagents |
| 11/30/2006 | US20060270855 Methods of preparing retroviral proteases inhibitor intermediates |
| 11/29/2006 | EP0738149B1 1-aminoindan derivatives and compositions thereof |
| 11/29/2006 | CN1869002A Class I non-steroid androgen acceptor regulator, its preparation method and use |
| 11/28/2006 | US7141696 N-alkyl-diphenyl-alkylene-amine derivatives; for the treatment of smooth muscle hyperactivity in urinary incontinence, gastrointestinal disorder, respiratory system disorder; promoting smooth muscle relaxation, reducing hypotension or cardiac side effects |
| 11/28/2006 | US7140433 oligomers and/or polymers formed by reacting a diamine and a primary amine-aldehyde reaction product, where the reaction product comprises substantially biomolecular adducts of primary amines aldehydes |
| 11/28/2006 | CA2239853C Indane dimer compounds and their pharmaceutical use |
| 11/23/2006 | US20060264674 Colorant compositions |
| 11/23/2006 | US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 11/23/2006 | US20060260072 Primary intermediate for oxidative coloration of hair |
| 11/22/2006 | EP1724013A1 Asymmetric reaction catalyst and process for production of optically active compounds with the same |
| 11/22/2006 | CN1867539A Method for the distillative separation of mixtures containing ethyleneamines |
| 11/22/2006 | CN1865227A Improved method for synthesizing antimalarial |
| 11/22/2006 | CN1865226A 3- methylamino-1-phenylpropanol preparation method |
| 11/21/2006 | US7138547 Antitumoral compounds |
| 11/21/2006 | US7138406 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders |
| 11/16/2006 | WO2006122259A1 Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid |
| 11/16/2006 | WO2006121187A1 Acrylic ester compound and manufacturing intermediate thereof, method for manufacturing acrylic ester compound, and latent electrostatic image bearing member, image forming method, image forming apparatus and process cartridge |
| 11/16/2006 | CA2604624A1 Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid |
| 11/15/2006 | EP1721889A1 Process for the preparation of phenethylamine derivatives |
| 11/15/2006 | EP0877607B1 Biphenyl compounds and use thereof as oestrogenic agents |
| 11/15/2006 | CN1863761A Method for separating triethanolamin from a mixture obtainable by ammonia and ethylene oxide reaction |
| 11/15/2006 | CN1861574A Purifying process of voigelibo saccharide |
| 11/15/2006 | CN1861573A Organic polyamine, its synthesizing process and use |
| 11/15/2006 | CN1861555A Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 11/14/2006 | US7135500 for treatment of inflammatory and obstructive respiratory complaints, bradycardic heart rhythm disorders, cardiovascular shock |
| 11/09/2006 | WO2006117616A1 Polymorphic form i of lumefantrine and processes for its preparation |
| 11/09/2006 | WO2006117339A1 Resorcinol-based mannich base |
| 11/09/2006 | US20060252963 Dendrimers, e.g.,(styryl)n phenyleneamines, allows direct control of the microscopic packing through chemical modification to provide a correlation between molecular structure of the molecules and device semiconductors |
| 11/09/2006 | US20060252836 Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability |
| 11/09/2006 | CA2605523A1 Resorcinol-based mannich base |
| 11/08/2006 | EP1718600A1 Synthesis of severely sterically hindered secondary aminoether alcohols from a ketene and/or carboxylic acid halide and/or carboxylic acid anhydride |
| 11/08/2006 | EP1324979B1 Ionic liquids and their use as solvents |
| 11/08/2006 | EP0993437B1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
| 11/02/2006 | WO2006114264A1 Acetylene derivatives |
| 11/02/2006 | WO2006114260A1 Phenylacetylene derivatives having mglur5 receptor affinity |
| 11/02/2006 | WO2006074873A3 New one-step synthesis of useful disubstituted amines |
| 11/02/2006 | US20060247264 Modulators of the Glucocorticoid Receptor |